Does the media prefer LFST or INNV?

In the previous week, LifeStance Health Group had 8 more articles in the media than InnovAge. MarketBeat recorded 10 mentions for LifeStance Health Group and 2 mentions for InnovAge. LifeStance Health Group's average media sentiment score of 1.28 beat InnovAge's score of 0.69 indicating that LifeStance Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, INNV or BLLN?

Billiontoone has lower revenue, but higher earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InnovAge $853.70M 1.71 -$30.31M -$0.09 N/A Billiontoone $305.11M 15.37 $7.45M $0.70 141.99

Does the media refer more to INNV or BLLN?

In the previous week, Billiontoone had 11 more articles in the media than InnovAge. MarketBeat recorded 13 mentions for Billiontoone and 2 mentions for InnovAge. InnovAge's average media sentiment score of 0.69 beat Billiontoone's score of 0.26 indicating that InnovAge is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate INNV or CRVL?

InnovAge presently has a consensus target price of $10.00, suggesting a potential downside of 6.98%. Given InnovAge's higher possible upside, research analysts plainly believe InnovAge is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InnovAge 2 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.75 CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, INNV or CRVL?

CorVel has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InnovAge $853.70M 1.71 -$30.31M -$0.09 N/A CorVel $958.53M 3.63 $110.34M $2.25 30.32

Is INNV or CRVL more profitable?

CorVel has a net margin of 11.72% compared to InnovAge's net margin of -1.22%. CorVel's return on equity of 29.92% beat InnovAge's return on equity. Company Net Margins Return on Equity Return on Assets InnovAge -1.22% -4.73% -2.20% CorVel 11.72% 29.92% 17.82%

Does the media favor INNV or CRVL?

In the previous week, CorVel had 6 more articles in the media than InnovAge. MarketBeat recorded 8 mentions for CorVel and 2 mentions for InnovAge. CorVel's average media sentiment score of 0.86 beat InnovAge's score of 0.69 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, OPCH or INNV?

Option Care Health has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Option Care Health $5.65B 0.64 $207.59M $1.33 18.20 InnovAge $853.70M 1.71 -$30.31M -$0.09 N/A

Does the media refer more to OPCH or INNV?

In the previous week, Option Care Health had 2 more articles in the media than InnovAge. MarketBeat recorded 4 mentions for Option Care Health and 2 mentions for InnovAge. Option Care Health's average media sentiment score of 1.13 beat InnovAge's score of 0.69 indicating that Option Care Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AVAH or INNV?

In the previous week, Aveanna Healthcare had 6 more articles in the media than InnovAge. MarketBeat recorded 8 mentions for Aveanna Healthcare and 2 mentions for InnovAge. Aveanna Healthcare's average media sentiment score of 1.16 beat InnovAge's score of 0.69 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

InnovAge (INNV) Competitors

$10.75 -0.02 (-0.19%)

As of 04:00 PM Eastern

Compare

INNV vs. LFST, BLLN, CRVL, OPCH, and AVAH

Should you buy InnovAge stock or one of its competitors? InnovAge's main competitors and comparable companies include LifeStance Health Group (LFST), Billiontoone (BLLN), CorVel (CRVL), Option Care Health (OPCH), and Aveanna Healthcare (AVAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does InnovAge compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

LifeStance Health Group has a net margin of 3.19% compared to InnovAge's net margin of -1.22%. LifeStance Health Group's return on equity of 3.39% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
InnovAge	-1.22%	-4.73%	-2.20%

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 12.3% of InnovAge shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by company insiders. Comparatively, 1.0% of InnovAge shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, LifeStance Health Group had 8 more articles in the media than InnovAge. MarketBeat recorded 10 mentions for LifeStance Health Group and 2 mentions for InnovAge. LifeStance Health Group's average media sentiment score of 1.28 beat InnovAge's score of 0.69 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeStance Health Group currently has a consensus target price of $12.38, suggesting a potential downside of 2.79%. InnovAge has a consensus target price of $10.00, suggesting a potential downside of 6.98%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, research analysts plainly believe LifeStance Health Group is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

LifeStance Health Group has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.47	$9.66M	$0.13	97.92
InnovAge	$853.70M	1.71	-$30.31M	-$0.09	N/A

LifeStance Health Group has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market. Comparatively, InnovAge has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market.

Summary

LifeStance Health Group beats InnovAge on 17 of the 17 factors compared between the two stocks.

How does InnovAge compare to Billiontoone?

InnovAge (NASDAQ:INNV) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

In the previous week, Billiontoone had 11 more articles in the media than InnovAge. MarketBeat recorded 13 mentions for Billiontoone and 2 mentions for InnovAge. InnovAge's average media sentiment score of 0.69 beat Billiontoone's score of 0.26 indicating that InnovAge is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	4 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Billiontoone has lower revenue, but higher earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$853.70M	1.71	-$30.31M	-$0.09	N/A
Billiontoone	$305.11M	15.37	$7.45M	$0.70	141.99

12.3% of InnovAge shares are owned by institutional investors. 1.0% of InnovAge shares are owned by company insiders. Comparatively, 50.2% of Billiontoone shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

InnovAge currently has a consensus price target of $10.00, indicating a potential downside of 6.98%. Billiontoone has a consensus price target of $125.88, indicating a potential upside of 26.65%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts clearly believe Billiontoone is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
Billiontoone	2 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.45

Billiontoone has a net margin of 8.04% compared to InnovAge's net margin of -1.22%. Billiontoone's return on equity of 9.96% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-1.22%	-4.73%	-2.20%
Billiontoone	8.04%	9.96%	5.35%

Summary

Billiontoone beats InnovAge on 12 of the 15 factors compared between the two stocks.

How does InnovAge compare to CorVel?

InnovAge (NASDAQ:INNV) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

InnovAge has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market. Comparatively, CorVel has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market.

InnovAge presently has a consensus target price of $10.00, suggesting a potential downside of 6.98%. Given InnovAge's higher possible upside, research analysts plainly believe InnovAge is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

CorVel has a net margin of 11.72% compared to InnovAge's net margin of -1.22%. CorVel's return on equity of 29.92% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-1.22%	-4.73%	-2.20%
CorVel	11.72%	29.92%	17.82%

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 1.0% of InnovAge shares are owned by insiders. Comparatively, 39.7% of CorVel shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, CorVel had 6 more articles in the media than InnovAge. MarketBeat recorded 8 mentions for CorVel and 2 mentions for InnovAge. CorVel's average media sentiment score of 0.86 beat InnovAge's score of 0.69 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CorVel has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$853.70M	1.71	-$30.31M	-$0.09	N/A
CorVel	$958.53M	3.63	$110.34M	$2.25	30.32

Summary

CorVel beats InnovAge on 14 of the 16 factors compared between the two stocks.

How does InnovAge compare to Option Care Health?

Option Care Health (NASDAQ:OPCH) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

In the previous week, Option Care Health had 2 more articles in the media than InnovAge. MarketBeat recorded 4 mentions for Option Care Health and 2 mentions for InnovAge. Option Care Health's average media sentiment score of 1.13 beat InnovAge's score of 0.69 indicating that Option Care Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Option Care Health	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Option Care Health has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, InnovAge has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market.

Option Care Health has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$5.65B	0.64	$207.59M	$1.33	18.20
InnovAge	$853.70M	1.71	-$30.31M	-$0.09	N/A

98.1% of Option Care Health shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 1.7% of Option Care Health shares are owned by insiders. Comparatively, 1.0% of InnovAge shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Option Care Health currently has a consensus target price of $29.92, indicating a potential upside of 23.60%. InnovAge has a consensus target price of $10.00, indicating a potential downside of 6.98%. Given Option Care Health's stronger consensus rating and higher possible upside, analysts plainly believe Option Care Health is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

Option Care Health has a net margin of 3.68% compared to InnovAge's net margin of -1.22%. Option Care Health's return on equity of 18.74% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Option Care Health	3.68%	18.74%	7.25%
InnovAge	-1.22%	-4.73%	-2.20%

Summary

Option Care Health beats InnovAge on 15 of the 16 factors compared between the two stocks.

How does InnovAge compare to Aveanna Healthcare?

Aveanna Healthcare (NASDAQ:AVAH) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Aveanna Healthcare has a beta of 1.97, indicating that its share price is 97% more volatile than the broader market. Comparatively, InnovAge has a beta of 0.4, indicating that its share price is 60% less volatile than the broader market.

88.0% of Aveanna Healthcare shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by company insiders. Comparatively, 1.0% of InnovAge shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Aveanna Healthcare had 6 more articles in the media than InnovAge. MarketBeat recorded 8 mentions for Aveanna Healthcare and 2 mentions for InnovAge. Aveanna Healthcare's average media sentiment score of 1.16 beat InnovAge's score of 0.69 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aveanna Healthcare has a net margin of 10.56% compared to InnovAge's net margin of -1.22%. Aveanna Healthcare's return on equity of 80.70% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
InnovAge	-1.22%	-4.73%	-2.20%

Aveanna Healthcare has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.22	$225.03M	$1.23	11.04
InnovAge	$853.70M	1.71	-$30.31M	-$0.09	N/A

Aveanna Healthcare presently has a consensus price target of $13.50, suggesting a potential downside of 0.59%. InnovAge has a consensus price target of $10.00, suggesting a potential downside of 6.98%. Given Aveanna Healthcare's stronger consensus rating and higher possible upside, research analysts plainly believe Aveanna Healthcare is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
InnovAge	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

Summary

Aveanna Healthcare beats InnovAge on 16 of the 17 factors compared between the two stocks.

Get InnovAge News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INNV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INNV vs. The Competition

Export

Metric	InnovAge	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.46B	$10.00B	$7.17B	$12.89B
Dividend Yield	N/A	2.56%	2.53%	8.57%
P/E Ratio	-119.44	34.60	273.00	25.40
Price / Sales	1.71	4.97	618.40	98.88
Price / Cash	N/A	120.90	77.82	52.27
Price / Book	6.11	3.99	12.86	6.17
Net Income	-$30.31M	$313.25M	$3.47B	$349.50M
7 Day Performance	-1.01%	1.17%	1.27%	-0.05%
1 Month Performance	-0.92%	0.40%	5.84%	0.80%
1 Year Performance	194.52%	15.62%	25.77%	15.58%

InnovAge Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INNV InnovAge	0.7524 of 5 stars	$10.75 -0.2%	$10.00 -7.0%	+185.7%	$1.46B	$853.70M	N/A	2,440	Upcoming Earnings
LFST LifeStance Health Group	3.2541 of 5 stars	$12.60 +1.9%	$12.38 -1.8%	+133.7%	$4.79B	$1.42B	96.93	10,961	Positive News
BLLN Billiontoone	4.2136 of 5 stars	$92.32 +1.8%	$126.71 +37.3%	N/A	$4.28B	$305.11M	129.53	620	Analyst Forecast
CRVL CorVel	1.4204 of 5 stars	$69.74 +1.2%	N/A	-21.2%	$3.51B	$958.53M	31.00	5,239	Analyst Upgrade Insider Trade
OPCH Option Care Health	4.2018 of 5 stars	$23.64 +0.8%	$29.92 +26.6%	-15.5%	$3.51B	$5.65B	17.77	8,266

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INNV) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InnovAge (INNV) Competitors

INNV vs. LFST, BLLN, CRVL, OPCH, and AVAH

How does InnovAge compare to LifeStance Health Group?

Summary

How does InnovAge compare to Billiontoone?

Summary

How does InnovAge compare to CorVel?

Summary

How does InnovAge compare to Option Care Health?

Summary

How does InnovAge compare to Aveanna Healthcare?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INNV vs. The Competition

InnovAge Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InnovAge (INNV) Competitors

INNV vs. LFST, BLLN, CRVL, OPCH, and AVAH

How does InnovAge compare to LifeStance Health Group?

Is LFST or INNV more profitable?

Do institutionals and insiders hold more shares of LFST or INNV?

Does the media prefer LFST or INNV?

Do analysts recommend LFST or INNV?

Which has better valuation & earnings, LFST or INNV?

Which has more risk & volatility, LFST or INNV?

Summary

How does InnovAge compare to Billiontoone?

Does the media refer more to INNV or BLLN?

Which has better valuation & earnings, INNV or BLLN?

Do institutionals & insiders have more ownership in INNV or BLLN?

Do analysts recommend INNV or BLLN?

Is INNV or BLLN more profitable?

Summary

How does InnovAge compare to CorVel?

Which has more volatility and risk, INNV or CRVL?

Do analysts rate INNV or CRVL?

Is INNV or CRVL more profitable?

Do institutionals & insiders hold more shares of INNV or CRVL?

Does the media favor INNV or CRVL?

Which has preferable valuation and earnings, INNV or CRVL?

Summary

How does InnovAge compare to Option Care Health?

Does the media refer more to OPCH or INNV?

Which has more volatility & risk, OPCH or INNV?

Which has stronger valuation and earnings, OPCH or INNV?

Do institutionals and insiders have more ownership in OPCH or INNV?

Do analysts rate OPCH or INNV?

Is OPCH or INNV more profitable?

Summary

How does InnovAge compare to Aveanna Healthcare?

Which has more volatility & risk, AVAH or INNV?

Do institutionals and insiders hold more shares of AVAH or INNV?

Does the media refer more to AVAH or INNV?

Is AVAH or INNV more profitable?

Which has better earnings & valuation, AVAH or INNV?

Do analysts rate AVAH or INNV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INNV vs. The Competition

InnovAge Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools